{"id":340404,"date":"2026-11-05T13:10:15","date_gmt":"2026-11-05T07:40:15","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=340404"},"modified":"2026-11-05T13:10:15","modified_gmt":"2026-11-05T07:40:15","slug":"engineering-and-construction-major-hospital-network-and-pharma-company-stocks-roadmap-headland-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/engineering-and-construction-major-hospital-network-and-pharma-company-stocks-roadmap-headland-list\/","title":{"rendered":"3 Engineering and Construction Major, Hospital Network and Pharma Company Stocks With a Strong Future Roadmap: Larsen & Toubro, Krishna Institute of Medical Sciences and Alkem Laboratories"},"content":{"rendered":"

Larsen & Toubro, Krishna Institute of Medical Sciences and Alkem Laboratories: ROE of 10.7% to 16.7% and FY22 to FY26 revenue CAGR of 9.1% to 23.8%. Prices as of 4 Nov 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The three engineering, hospital chain and pharma stocks to watch are Larsen & Toubro, Krishna Institute of Medical Sciences and Alkem Laboratories. Their return on equity ranges from 10.7% to 16.7%, and their revenue compound annual growth from FY22 to FY26 ranges from 9.1% to 23.8%. Alkem Laboratories has the highest return on equity at 16.7%, while Krishna Institute of Medical Sciences has the fastest revenue growth at 23.8% a year. Prices are based on the 4 November 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n

Engineering, hospital chain and pharma stocks bring together companies with a visible plan for the years ahead. Larsen & Toubro, Krishna Institute of Medical Sciences and Alkem Laboratories cover an engineering and construction conglomerate, a multi speciality hospital network and a pharmaceutical company.<\/p>\n

This list covers three engineering, hospital chain and pharma stocks with complete current figures: Larsen & Toubro, Krishna Institute of Medical Sciences and Alkem Laboratories. Every figure comes from the latest reported financials and the 4 November 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/a><\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n